fda warning letters compounding semaglutide october 2025 warns telehealth companies over compounded GLP-1s Beyond the Headlines: FDA Warning

We further validated our findings in a different mouse model involving lipid peroxidation: doxorubicin induced liver damage (Supplementary Fig

1-6 Secondary carnitine deficiency can be a consequence of inborn errors of metabolism

When AMPK is activated, cells may improve their ability to use glucose and respond to insulin signaling

Mobilization of toxins can lead to complications, and patients with extreme toxicity should seek medical help

Understanding the mechanism helps you appreciate why retatrutide produces different results than tirzepatide and why the transition is worth the effort for the right candidates

AKAP1 contributes to impaired mtDNA replication and mitochondrial dysfunction in podocytes of diabetic kidney disease